Company Filing History:
Years Active: 2008
Title: Sean A. Bulloch: Innovator in Immunology
Introduction
Sean A. Bulloch is a notable inventor based in Cupertino, California. He has made significant contributions to the field of immunology through his innovative work. His research focuses on the development of human receptors and membrane-associated proteins, which have important implications for diagnosing and treating various disorders.
Latest Patents
Sean A. Bulloch holds a patent for a CD40-related receptor that binds CD40L. This invention encompasses various embodiments that provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides, which identify and encode REMAP. Additionally, the patent includes expression vectors, host cells, antibodies, agonists, and antagonists. The methods outlined in the patent aim to diagnose, treat, or prevent disorders associated with aberrant expression of REMAP.
Career Highlights
Sean A. Bulloch is currently employed at Incyte Corporation, where he continues to advance his research in immunology. His work at Incyte has allowed him to collaborate with other leading scientists in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Narinder K. Chawla and Henry Yue. Their collaborative efforts contribute to the innovative environment at Incyte Corporation.
Conclusion
Sean A. Bulloch is a distinguished inventor whose work in immunology has led to significant advancements in the understanding and treatment of various disorders. His contributions continue to shape the future of medical research and innovation.